The table below shows TG THERAPEUTICS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$616.29M
$329.00M
$233.66M
$2.79M
$6.69M
$152.00K
Cost of revenue
$100.71M
$38.49M
$14.13M
$265.00K
$790.00K
-
Gross profit
-
-
-
-
-
-
R&D
$160.22M
$94.29M
$76.19M
$125.35M
$222.58M
$165.90M
SG&A
TGTX annual revenue (10-K history)
TG THERAPEUTICS, INC. reported annual revenue of $616.29M for fiscal year 2025. That is up 87.3% from $329.00M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $152.00K (FY 2016) to $616.29M. Figures come from the company's audited annual reports as filed with the SEC.
